Cyclosporin-A in severe refractory anemia of myelofibrosis with myeloid metaplasia: A preliminary report

Haematologica

Volumn 83, Issue 7, 1998, Pages 622-626

  Centenara, Esther ^a   Guarnone, Roberta ^a   Ippoliti, Giovanbattista ^a   Barosi, Giovanni ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Anemia; CD4 CD8 ratio; Cyclosporin A; Immune disorders; Myelofibrosis with myeloid metaplasia

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOSPORIN A; ERYTHROPOIETIN; INTERLEUKIN 2 RECEPTOR; MITOCHONDRION ANTIBODY; PREDNISONE; TRANSFERRIN RECEPTOR;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; GINGIVA HYPERPLASIA; HUMAN; IMMUNOPATHOLOGY; LEUKOCYTE COUNT; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PARESTHESIA; PREDICTION; REFRACTORY ANEMIA;

ADULT; AGED; ANEMIA, REFRACTORY; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA;

EID: 0031904018     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Visani G, Finelli C, Castelli U, et al. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. Br J Haematol 1990; 75:4-9.
2. Tefferi A, Silverstein MN. Current perspective in agnogenic myeloid metaplasia. Leuk Lymphoma 1996; 2251:169-71.
3. Leonard EM, Raefsky E, Griffith P, Kimball J, Nienhuis AW, Young NS. Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol 1989; 72:278-84.
4. Raghavachar A. Pure red cell aplasia: review of treatment and proposal for a treatment strategy. Blut 1990; 61:47-51.
5. Hersko C, Sonnenblick M, Ashkenazi J. Control of steroid-resistant autoimmune haemolytic anaemia by cyclosporin. Br J Haematol 1990; 76:436-7.
6. Rondeau E, Solal-Celigny P, Dhermy D, et al. Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis. Br J Haematol 1983; 53:467-75.
7. Lang JM, Oberling F, Giron C, MayerS. Autoimmunité et deficit de immunité cellulaire au cours des fibroses primitives de la moelle osseuse. Ann Immunol Paris 1977; 128:291-3.
8. Caligaris Cappio F, Vigliani R, Novarino A, Camussi G, Campana D, Gavosto F. Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 1981; 49:17-21.
9. Khumbanonda M, Horowitz HI, Eysker ME. Coomb's positive hemolytic anemia in myelofibrosis with myeloid metaplasia. Am J Med Sci 1969; 258:89-93.
10. Bernhardt B, Valletta M. Lupus anticoagulant in myelofibrosis. Am J Med Sci 1976; 272:229-31.
11. Hasselbalch H, Berild D, Paaske-Hansen O. Platelet associated IgG and IgM in myelofibrosis. Scand J Haematol 1984; 32:488-92.
12. Gordon BR, Coleman M, Kohen P, Day NK. Immunological abnormalities in myelofibrosis with activation of the complement system. Blood 1981; 58:904-10.
13. Wang JC, Wang A. Plasma soluble interleukin-2 receptor in patients with primary myelofibrosis. Br J Haematol 1994; 86:380-2.
14. Soppi E, Nousiainen T, Seppa A, Lahtinen R. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in association with myelodysplastic syndromes: a report of three cases and a review of the literature. Br J Haematol 1989; 73:43-7.
15. Hasle H, Jacobsen BB, Pedersen NT. Myelodysplastic syndromes in childhood: a population based study of nine cases. Br J Haematol 1992; 81:495-8.
16. Cazzola M, Ponchio L, Beguin Y, et al. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders; results of a phase I/II clinical trial. Blood 1992; 79:29-37.
17. Lewis CM, Pegrum GD. Immune complexes in myelofibrosis: a possible guide to management. Br J Haematol 1978; 39:233-9.
18. Vannucchi AM, Grossi A, Bosi A, et al. Impaired erythropoietin production in mice treated with cyclosporin A. Blood 1991; 78:1615-8.
19. Pietrasanta D, Clavio M, Vallebella E, Beltrami G, Cavaliere M, Gobbi M. Long-lasting effect of cyclosporin-A on anemia associated with idiopathic myelofibrosis. Haematologica 1997; 82:458-9.
20. Grady RW, Akbar AN, Giardina PJ, Hilgartner MW, de Sousa M. Disproportionate lymphoid cell subsets in thalassaemia major: the relative contributions of transfusion and splenectomy. Br J Haematol 1985; 59:713-24.